| 000 | 01639 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517002003.0 | ||
| 264 | 0 | _c20150423 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1536-3678 | ||
| 024 | 7 |
_a10.1097/MPH.0000000000000277 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeym, Kenneth M | |
| 245 | 0 | 0 |
_aNonhematologic toxicity of imatinib mesylate in pediatric patients with chronic myelogenous leukemia: a predominance of musculoskeletal pain. _h[electronic resource] |
| 260 |
_bJournal of pediatric hematology/oncology _cMar 2015 |
||
| 300 |
_ae111-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBenzamides _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMusculoskeletal Pain _xchemically induced |
| 650 | 0 | 4 |
_aPiperazines _xadverse effects |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPyrimidines _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGressett Ussery, Sarah M | |
| 700 | 1 | _aTrinkman, Heidi | |
| 700 | 1 | _aPhilpot, Lindsey M | |
| 773 | 0 |
_tJournal of pediatric hematology/oncology _gvol. 37 _gno. 2 _gp. e111-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MPH.0000000000000277 _zAvailable from publisher's website |
| 999 |
_c24332909 _d24332909 |
||